Skip to main content

Month: September 2024

Form 8.3 – [ECKOH PLC – 13 09 2024] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ECKOH PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Nokia selected by CoreWeave to provide networking backbone behind hyperscale AI cloud

Press releaseNokia selected by CoreWeave to provide networking backbone behind hyperscale AI cloudCoreWeave to deploy Nokia IP and optical platforms in datacenters across U.S. and Europe as part of massive wide area network buildout to support high-performance AI infrastructure Nokia ultra-fast, reliable performance at scale supports the lossless, low latency communications so critical to enabling the AI boom16 September 2024Espoo, Finland – Nokia today announced it has been selected by CoreWeave, the AI Hyperscaler™, to deploy its IP routing and optical transport portfolios globally as part of an extensive backbone build-out, with immediate roll-out across its datacenters in the U.S. and Europe. The Nokia solution provides super-fast, reliable performance at scale, while driving 30%+ more traffic within the same energy envelope...

Continue reading

Immatics Presents Clinical Proof-of-Concept Data from Ongoing Phase 1 Dose Escalation Trial with TCR Bispecific Molecule TCER® IMA401 Targeting MAGEA4/8 at ESMO 2024 and Provides Development Update

TCER® IMA401 is a novel, next-generation, half-life extended bispecific T cell engager directed against an HLA-A*02-presented peptide derived from MAGEA4 and MAGEA8 with high target copy numbers on various solid cancersData from the first-in-human Phase 1 dose escalation trial demonstrate initial anti-tumor activity and a manageable tolerability profile for TCER® IMA401 monotherapy; patient population includes 35 heavily pre-treated patients across 16 different solid tumor types; dose escalation is ongoingObjective response rate (ORR) 29%, confirmed ORR (cORR) 25%, disease control rate (DCR) of 53% and tumor shrinkage rate of 53% in the efficacy population treated with relevant IMA401 doses and MAGEA4/8 target levels1Objective responses observed in head and neck squamous cell carcinoma, neuroendocrine tumor, cutaneous and mucosal...

Continue reading

Nova Klúbburinn hf.: Framkvæmd endurkaupaáætlunar í viku 37

Í 37. viku 2024 keypti Nova Klúbburinn hf. 2.686.000 eigin hluti að kaupverði 9.899.320 kr. í samræmi við eftirfarandi:Dagsetning Tími Keyptir hlutir Viðskiptaverð (gengi) Kaupverð (kr.)09/09/2024 15:10:04 588.000 3.70 2.175.60010/09/2024 09:33:42 467.000 3.69 1.723.23010/09/2024 11:56:50 458.000 3.68 1.685.44011/09/2024 11:35:34 507.000 3.69 1.870.83013/09/2024 12:52:04 666.000 3.67 2.444.220Samtals 2.686.000   9.899.320Viðskiptin eru í samræmi við endurkaupaáætlun Nova Klúbbsins sem tilkynnt var um í Kauphöll Íslands hf. þann 24. apríl 2024. Endurkaup munu samkvæmt áætluninni nema að hámarki 550 milljónum kr. að kaupverði og mun áætlunin vera í gildi þar til því hámarki er náð, þó aldrei lengur en fram að aðalfundi félagins 2025. Nova Klúbburinn átti 51.782.000 eigin hluti fyrir viðskiptin og á því að þeim loknum...

Continue reading

Share buyback programme – week 37

Nasdaq CopenhagenEuronext DublinLondon Stock ExchangeOther stakeholders Date        16 September 2024 Share buyback programme – week 37 The share buyback programme runs in the period 1 February 2024 up to and including 27 January 2025, see company announcement of 31 January 2024. Part I of the programme, for DKK 750 million, was completed on 27 June 2024, see company announcement of 28 June 2024. Part II of the programme, for DKK 775 million and a maximum of 1,550,000 shares, is for execution in the period 28 June 2024 – 27 January 2025. The programme is implemented in compliance with EU Commission Regulation No. 596/2014 of 16 April 2014 and EU Commission Delegated Regulation No. 2016/1052 of 8 March 2016, which together constitute the “Safe Harbour” rules. The following transactions have been made under the programme:Date Number...

Continue reading

Kronos Advanced Technologies, Inc. (OTC: KNOS) Announces Ex-Dividend Date for Upcoming Special Cash Dividend

Los Angeles, CA, Sept. 16, 2024 (GLOBE NEWSWIRE) — Los Angeles, CA September 16, 2024– Kronos Advanced Technologies, Inc. (OTC: KNOS), a leading innovator in advanced air purification technology, is pleased to announce that last Friday, after the markets closed, FINRA officially set the ex-dividend date for its upcoming cash dividend of $0.00001 per share. The ex-dividend date is set for midnight (12:00 AM) on September 18, 2024 The cash dividend will be paid to shareholders of record as of the close of business on December 18, 2024. Shareholders who own KNOS shares on and up to the close of business prior to the ex-dividend date will be eligible to receive the dividend. This marks another step in Kronos’ ongoing commitment to deliver value to its shareholders. Shareholders are advised that any shares purchased on or after...

Continue reading

Aktsiaselts Infortar signed a share purchase agreement to acquire a 100% shareholding at Tallinna Raamatutrükikoja Osaühing

Aktsiaselts Infortar (registry code: 10139414) and ViroInvestment OÜ (registry code: 16894198) signed a share purchase agreement on September 13, 2024 to acquire a 100% shareholding at Tallinna Raamatutrükikoja Osaühing (TRT) (registry code: 10224203). According to the agreement, obtaining approval from the Competition Authority and completion of additional operations are preconditions for closing of the transaction. “Tallinna Raamatutrükikoda is one of the most recognized players in its field. In many manufacturing and export industries, consolidation is a common trend and key to unlocking additional efficiencies. This helps secure positions in both domestic and international markets,” noted Priit Tamme, Deputy Managing Director of Infortar. TRT main area of activity is printing of books, approximately 5 million printed materials...

Continue reading

Syensqo announces voluntary delisting from Euronext Paris

Syensqo announces voluntary delisting from Euronext Paris Brussels, Belgium – September 16, 2024 08:30 CEST  SYENSQO announces today that, as part of a strategy to simplify its listing structure, and following a  review of the direct and indirect cost and administrative requirements related to its listing on Euronext  Paris while maintaining a similar listing on Euronext Brussels, it has decided to apply for the delisting  of its shares (ISIN Code BE0974464977) from Euronext Paris (the “Delisting”). The Delisting has been  approved by the Listing Board of Euronext Paris S.A. The Syensqo Shares will be delisted from Euronext Paris on 30 September (the “Delisting Date”). The contemplated timetable of the Delisting can be summarized as follows: Event  DateLast day of trading of Syensqo Shares on Euronext Paris  27 September 2024Delisting...

Continue reading

SEB initiates coverage of Aktia and publishes initiation analysis

Aktia Bank PlcPress release16 September 2024 at 9.15 a.m. SEB initiates coverage of Aktia and publishes initiation analysis Aktia has entered into an agreement with SEB regarding equity research on Aktia, and today SEB has published its initiation analysis. This means that the number of analyst firms covering Aktia now increases to three. Aktia endeavours to meet investors’ need for professional equity research, and therefore it has been an objective to increase the number of analysts covering Aktia. This also contributes to increasing awareness of Aktia among investors, both in Finland and abroad. ‘It is important for us to ensure that investors have sufficient information to form an assessment of Aktia as an investment. I am convinced that SEB’s recognised and appreciated analytical work will help to further improve investors’...

Continue reading

Sampo plc’s share buybacks 13 September 2024

SAMPO PLC                 STOCK EXCHANGE RELEASE                  16 September 2024 at 8:30 am Sampo plc’s share buybacks 13 September 2024 On 13 September 2024, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  4,399 41.60 AQEU          43,618 41.58 CEUX  1,163 41.59 TQEX  45,016 41.58 XHELTOTAL 94,196 41.58  *rounded to two decimals                 On 17 June 2024, Sampo announced a share buyback programme of up to a maximum of EUR 400 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.